Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1438-1446

  Iuliano, L ^a   Colavita, A R ^a   Camastra, C ^a   Bello, V ^a   Quintarelli, C ^a   Alessandroni, M ^a   Piovella, F ^b   Violi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Institute of Clinical Medicine II   (Italy)

Author keywords

Antioxidants; Atherosclerosis; Dipyridamole; Free radicals; Lipoproteins

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; APOPROTEIN; ASCORBIC ACID; COPPER ION; DIPYRIDAMOLE; HYDROGEN PEROXIDE; HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; OXYGEN RADICAL; PROBUCOL; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029803453     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16056.x     Document Type: Article

References (54)

1. APT COLLABORATION. (1988). Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br. Med. J., 296, 320-331.
2. AUTIO, I., JAAKKOLA, O., SOLAKIVI, T. & NIKKARI, T. (1990). Oxidized low density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett., 227, 247-249.
3. BELCHER, J.D., BALLA, J., JACOBS, D.R., GROSS, M., JACOB, H. & VERCELLOTTI, G.M. (1993). Vitamin E, LDL, and endothelium. Brief oral vitamin E supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler. Thromb., 13, 1779-1789.
4. BILHEIMER, D.W., EISENBERG, S. & LEVY, R.I. (1972). The metabolism of very low density lipoproteins. Biochim. Biophys. Acta, 260, 212-221.
5. BOWRY, V.W. & STOCKER, R. (1993). Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc., 115, 6029-6044.
6. BOYD, H.C., GROWN, A.M., WOLFBAUER, G. & CHAIT, A. (1989). Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from Watanabe heritable hyperlipidemic rabbits. Am. J. Pathol., 135, 815-825.
7. BULL, A.W. & MARNETT, L.J. (1985). Determination of malondialdehyde by ion-pairing high performance liquid chromatography. Anal. Biochem., 149, 284-290.
8. BURTON, G.W. & INGOLD, K.U. (1986). Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res., 19, 194-201.
9. CAREW, T.E., SCHWNKE, D.C. & STEIMBERG, D. (1987). Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A., 84, 7725-7729.
10. CATHCART, M.K., MCNALLY, A.K., MOREL, D.W. & CHISOLM, G.M. (1989). Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipioprotein to a cytotoxin. J. Immunol., 142, 1963-1969.
11. CHILSOLM, G.M. (1991). Antioxidants and atherosclerosis: a current assessment. Clin. Cardiol., 14, I-25-3Q.
12. COMINACINI, L., GARBIN, U., DAVOLI, A., MICCIOLO, R., BOSELLO, O., GAVIRAGHI, G., SCURO, L.A. & PASTORINO, M. (1991). A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J. Lipid Res., 32, 349-358.
13. COMINACINI, L., GARBIN, U., PASTORINO, A.M., DAVOLI, A., CAMPAGNOLA, M., DE SANTIS, A., PASINI, C., FACCINI, G.B., TREVISAN, M.T., BERTOZZO, L., PASINI, F. & LO CASCIO, V. (1993). Predisposition of LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis, 99, 63-70.
14. CRAMER, G.L., MILLER, J.F., PENDLETON, R.B. & LANDS, W.E.M. (1991). Iodometric measurement of lipid hydroperoxides in human plasma. Anal. Biochem., 193, 204-211.
15. DE LA CRUZ, J.P., CARRASCO T., ORTEGA, G. & SANCHEZ DE LA CUESTA, F. (1992). Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids, 27, 192-194.
16. DIEBER-ROTHENEDER M., PUHL, H., WAEG, G., STRIEGEL, G. & ESTERBAUER, H. (1991). Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid. Res 32, 1325-1332.
17. ESTERBAUER, H., GEBICKI, J., PUHL, H. & JURGENS, G. (1992). The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med., 13, 341-390.
18. FITZGERALD, G.A. (1987). Dipyridamole. New Engl. J. Med., 316, 1247-1257.
19. FRANKEL-CONRAT, H. (1957). Methods for investigating the essential groups for enzyme activity. Methods Enzymol., 4, 247-269.
20. FREYSCHUSS, A., STIKO-RAHM, A., SWEDENBORG, J., HENRIKSSON, P., BJORKHEM, I., BEROLUND, L. & NILSSON, J. (1993). Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J. Clin. Invest., 91, 1282-1288.
21. GOLDSTEIN, J.L. & BROWN, M.S. (1974). Binding and degradation of low density lipoproteins by cultured human fibroblasts. J. Biol. Chem., 249, 5153-5162.
22. GOLDSTEIN, J.L., HO, J.K., BASU, S.K. & BROWN, M.S. (1979). Binding sites on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A., 76, 333-337.
23. HABEEB, A.F.S.A. (1966). Determination of free amino groups in proteins by trinitrobenzene sulphonic acid. Anal. Biochem., 14, 328-336.
24. HABERLAND, M.E., FONG, D. & CHENG, L. (1988). Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science, 241, 215-218.
25. HARATS, D., BEN-NAIM, M., DABACH, Y., HOLLANDER, G., HAVIVI, E., STEIN, O. & STEIN, Y. (1990). Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis, 85, 47-54.
26. HATCH, F.T. & LEES, R.S. (1968). Practical methods for plasma lipoprotein analysis. Adv. Lipid Res., 6, 1-68.
27. HESS, H., MIETASCHK, A. & DEICHSEL, G. (1985). Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial. Lancet, i, 415-419.
28. IULIANO, L., PEDERSEN, J.Z., PRATICO, D., ROTILIO, G. & VIOLI, F. (1994a). Role of hydroxyl radicals in the activation of human platelets. Eur. J. Biochem., 221, 695-704.
29. IULIANO, L., PEDERSEN, J.Z., ROTILIO, G., FERRO, D. & VIOLI, F. (1995). A potent chain breaking activity of the cardiovascular drug dipyridamole. Free Rad. Biol. Med., 18, 239-247.
30. IULIANO, L., PRATICÒ, D., GHISELLI, A., BONAVITA, M.S. & VIOLI, F. (1992). Reaction of dipyridamole with the hydroxyl radical. Lipids, 27, 349-353.
31. IULIANO, L., QUINTARELLI, C., ALESSANDRONI, M., ALESSANDRI, C., COLAVITA, A.R. & VIOLI, F. (1994b). Dipyridamole is a powerful antioxidant that inhibits LDL oxidation by endothelial cells. Clin. Res., 42, 178A.
32. IULIANO, L., VIOLI, F., GHISELLI, A., ALESSANDRI, C. & BALSANO, F. (1989). Dipyridamole inhibits lipid peroxidation and scavenges oxygen free radicals. Lipids, 24, 430-433.
33. JAFFE, E.A., NACHMAN, R.L., BECKER, C.G. & MINICK, C.R. (1973). Culture of human endothelial cells derived from human umbilical veins. J. Clin. Invest., 27, 2745-2756.
34. JANERO, D.R., BURGHARDT, B., LOPEZ, R. & CARDELL, M. (1989). Influence of cardioprotective cyclooxygenase and lipooxygenase inhibitors on peroxidative injury to myocardial-membrane pbospholipid. Biochem. Pharmacol., 38, 4381-4386.
35. JIALAL, I. & GRUNDY, S.M. (1992). Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J. Lipid. Res., 33, 899-906.
36. KUZUYA, M. & KUZUYA, F. (1993). Probucol as antioxidant and antiatherogenic drug. Free Rad. Biol. Med., 14, 66-77.
37. KUZUYA, M., NAITO, M., FUNAKI, C., HAYASHI, T., ASAI, K. & KUZUYA, F. (1991). Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim. Biophys. Acta, 1096, 155-161.
38. LARANJINHA, J.A.N., ALMEIDA, L.M. & MADEIRA, V.M.C. (1992). Lipid peroxidation and its inhibition in low density lipoproteins, quenching of cis-parinaric acid fluorescence. Arch. Biochem. Biophys., 297, 147-154.
39. MCLEAN, L.R. & HAGAMAN, K.A. (1989). Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper. Biochemistry, 28, 321-327.
40. MORISAKI, N., SLITTS, J.M., BARTELS-TOMEI, L., MILIO, G.E., PANGANAMALA, R.V. & CORNWELL, D.G. (1982). Dipyridamole, an antioxidant that promotes the proliferation of aorta smooth muscle cells. Artery, 11, 88-107.
41. PALINSKI, W., ROSENFELD, M.E., YLA-HERTTUALA, S., GURTENER, G.C., SOCHER, S.S., BUTLER, S.W., PARTHASARATHY, S., CAREW, T.E., STEINBERG, D. & WITZTUM, J.L. (1989). Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U.S.A., 86, 372-1376.
42. PRINCEN, H.M.G., VAN POPPEL, G., VOGELEZANG, C., BUYTENHEK, R. & KOK, F.J. (1992). Supplementation with vitamin E but not β-caroten in vivo protects low density lipoprotein from lipid peroxidation in vitro, effect of cigarette smoking. Arterioscler. Thromb., 12, 554-562.
43. QUINN, M.T., PARTHASARATHY, S., FONG, L.G. & STEINBERG, D. (1987). Oxidatively modified low density lipoproteins, a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. U.S.A., 84, 2995-2998.
44. REAVEN, P.D., KHOUW, A., BELTZ, W.F., PARTHASARATHY, S. & WITZTUM, J.I. (1993). Effect of dietary antioxidant combinations in humans. Arterioscler. Thromb., 13, 590-600.
45. REGNSTROM, J., NILSSON, J., TORNVALL, P., LANDOU, C. & HAMSTEN, A. (1992). Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet, 339, 1183-1186.
46. RICE-EVANS, C.A. & DIPLOCK, A.T. (1993). Current status of antioxidant therapy. Free Rad. Biol. Med., 15, 77-96.
47. SALONEN, J.T., YLÄ-HERTTUALA, S., YAMAMOTO, R., BUTLER, S., KORPELA, H., SALONEN, R., NYYSSÖNEN, K., PALINSKI, W. & WITZTUM, J.L. (1992). Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet, 339, 883-887.
48. SELLEY, M.L., CZETI, A.L., MCGUINESS, J.A. & ARDLIE, N.G. (1994). Dipyridamole inhibits the oxidative modification of low density lipoprotein. Atherosclerosis, 111, 91-97.
49. SMITH, P.K., KROHN, R.I., HERMANSON, G.T., MALLIA, A.K., GARTNER, F.H., PROVENZANO, M.D., FUJIMOTO, E.K., GOEKE, N.M., OLSON, B.J. & KLENT, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
50. SPARROW, C.P., DOEBBER, T.W., OLSZEWSKI, J., WU, M.S., VENTRE, J., STEVENS, K.A. & CHAO, Y. (1992). Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N′,N‰-diphenyl-phenylenediamine. J. Clin. Invest., 89, 1885-1891.
51. STEINBERG, D., PARTHASARATHY, C., CAREW, T.E., KHOO, J.C. & WITZUM, J.L. (1989). Beyond cholesterol Modifications of low density lipoproteins that increases its atherogenicity. New Engl. J. Med., 320, 915-919.
52. STEINBRECHER, U.P., LOUGHEEED, M., KWAN, W.-C. & DIRKS, M. (1989). Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivativization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem., 264, 15216-15223.
53. TABAK, M. & BORISEVITCH, I.E. (1992). Interaction of dipyridamole with micelles of lysophosphatidylcholine and with bovine serum albumin, fluorescence studies. Biochim. Biophys. Acta, 1116, 241-249.
54. YLA-HERTTUALA, S., PALINSKI, W., ROSENFELD, M.E., PARTHASARATHY, S., CAREW, T.E., BUTLER, S., WITZTUM, J.L. & STEIMBERG, D. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest., 84, 1086-1095.